Observational study evaluates treatment response in breast cancer using dual-energy computed tomography metrics, highlighting their potential for imaging evaluation.
Changes in DECT-derived quantitative parameters, especially venous-phase ΔNIC%, ΔλHU%, and ΔED%, were associated with response to neoadjuvant chemotherapy in breast cancer, indicating the potential of DECT-based metrics to support imaging evaluation of treatment response.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: